- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02237014
Accuracy of Peripheral Pulse Oximetry Versus Arterial Co-oximeter in Children With Cyanotic Heart Disease
Study Overview
Status
Conditions
Detailed Description
Peripheral pulse oximetry allows continuous non-invasive measurement of arterial oxygen saturation, but the gold standard for arterial oxygen saturation is co-oximeter which requires an arterial blood sample. The purpose of this research study is to determine the accuracy of a pulse oximeter with a standard sensor (Masimo LNCS sensor) versus with the study sensors, namely Masimo blue sensor and Nellcor Max-I sensors and compared against co-oximetry. Currently available peripheral oximeters (standard) are inaccurate at low oxygen saturation noted in children with cyanotic heart disease. Hence therapeutic interventions (including surgery and cardiac catheterizations) based solely on peripheral oximetry can be delayed and or inadequate. By doing this study we will be able to establish correct limits of peripheral pulse oximeter when using the standard and the study sensors.
The investigator hopes to learn the limits of accuracy of currently available and used pulse oximeters. In children with cyanotic heart disease the "blue sensor" has been found in small studies to be more accurate compared to the "standard" pulse oximeter.
This study is important as it will provide information as to which pulse oximeter should be routinely used in children with cyanotic heart disease and to assess which SPO2 even with blue sensor is borderline and therefore the physician will know to obtain arterial blood sample for co-oximeter prior to planning important procedures based on a saturation reading.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children from LPCH undergoing cardiac catheterization or heart surgery in SUMC or LPCH respectively
- Peripheral arterial saturation less than or equal to 90% at time of enrollment
- weigh between 3-20 kg
- Less than or equal to 10 years of age
Exclusion Criteria:
- Lack of consent
- Greater than 10 years of age
- Less than 3 kg or more than 20 kg in weight
- Peripheral arterial saturation greater than 90% at time of enrollment
- Lack of arterial access
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of Peripheral Pulse Oximetry versus Arterial Co-oximeter in Children with Cyanotic Heart Disease
Time Frame: 2 year
|
The primary outcome measure is to describe the bias and precision between the Masimo blue sensor and co-oximetry.
|
2 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
establish correct limits of peripheral pulse oximeter when using the standard and the study sensors.
Time Frame: 2year
|
The secondary measure was to describe the limits of the blue sensor and standard sensor accuracy as compared with the co-oximeter.
If the test sensors consistently have a bias greater than 2 SD from the co-oximeter value at saturations lower than eg., 80 then the recommendation would be that the co-oximetry be used to measure patients saturatioin rather than relying on pulse oximtery alone for clinical decision making
|
2year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chandra Ramamoorthy, MD, Department of Anesthesia, Stanford University School of Medicine
Publications and helpful links
General Publications
- Cox P: New pulse oximetry sensors with low saturation accuracy claims-a clinical evaluation [Internet]. Anesthesiology 2007; 107:A1540
- Ross PA, Newth CJ, Khemani RG. Accuracy of pulse oximetry in children. Pediatrics. 2014 Jan;133(1):22-9. doi: 10.1542/peds.2013-1760. Epub 2013 Dec 16.
- Harris BU, Char DS, Feinstein JA, Verma A, Shiboski SC, Ramamoorthy C. Accuracy of Pulse Oximeters Intended for Hypoxemic Pediatric Patients. Pediatr Crit Care Med. 2016 Apr;17(4):315-20. doi: 10.1097/PCC.0000000000000660.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-11062012-11219
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cyanotic Heart Disease
-
Great Ormond Street Hospital for Children NHS Foundation...CompletedCalprotectin | Cyanotic Heart DiseaseUnited Kingdom
-
Assiut UniversityUnknownCongenital; Cyanotic Heart Disease
-
Aga Khan UniversityRecruitingCardiopulmonary Bypass | Cyanotic Heart DiseasePakistan
-
Seoul National University HospitalCompletedCyanotic Congenital Heart DiseaseKorea, Republic of
-
Cukurova UniversityCompletedPediatric HD | Cyanotic Congenital Heart DiseaseTurkey
-
University of California, DavisCompletedCyanotic Congenital Heart DiseaseUnited States
-
Universitas Sumatera UtaraIndonesia UniversityCompletedCyanotic Congenital Heart DiseaseIndonesia
-
Pediatric Clinical Research PlatformUniversity Hospital, GenevaRecruitingPneumonia | Asthma | Respiratory Diseases | Cyanotic Heart DiseaseSwitzerland
-
University of California, San DiegoTerminatedAnemia | Congenital Heart Disease | Cyanotic Congenital Heart Disease | CyanosisUnited States
-
Lifetech Scientific (Shenzhen) Co., Ltd.UnknownFeasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHDPatent Ductus Arteriosus | Duct-dependent Cyanotic Congenital Heart DiseaseMalaysia